Abstract:(1) Background: Toad venom (Bufonis Venenum, known as 'Chansu' in Chinese), the secretion of the ear-side gland and skin gland of Bufo gargarizans cantor or Duttaphrynus melanostictus Schneider, has been utilized to treat several diseases in China for thousands of years. However, due to the chemical variability of the components, systematic chemical composition and the key pharmacophores in toad venom have not yet fully understood. Besides, it contains a variety of effective compounds with different physiological activity and chemotypes, mainly including alkaloids, bufogenins, bufotoxins, and so on. The recent pharmacological researches have demonstrated that several bufogenins have remarkable pharmacological effects, such as anti-inflammatory, analgesic effects, and anti-tumor effects. Aim of the study: To identify the bioactive compounds and pharmacophores originating from toad venom based on analyzing spectrum-effect relationship by chemometrics and to explore the anti-cancer mechanism primarily. (2) Materials and methods: Fingerprint of the 21 batches of samples was established using HPLC (High Performance Liquid Chromatography). The anti-tumor activity of extracts were determined by in-vitro assays. Chemometric analysis was used to establish the spectrum-effect model and screen for active ingredients. Pharmacodynamic tests for the screened active compound monomers were conducted with in-vitro assays. Further anti-tumor mechanisms were investigated using western blot and flow cytometry. (3) Results: The established spectrum-effect model has satisfactory fitting effect and predicting accuracy. The inhibitory effect of major screened compounds on lung carcinoma cells A549 were validated in vitro, demonstrating that arenobufagin, telocinobufogenin, and cinobufotalin had significant anti-tumor effects. Through further investigation of the mechanism by western blotting and flow cytometry, we elucidated that arenobufagin induces apoptosis in A549 cells with the enhanced expression of cleaved PARP (poly (ADP-ribose) polymerase). These results may provide valuable information for further structural modification of bufadienolides to treat lung cancer and a method for discovery of anti-tumor active compounds. Conclusions: Our research offers a more scientific method for screening the principal ingredients dominating the pharmacodynamic function. These screened compounds (arenobufagin, etc.) were proven to induce apoptosis by overactivation of the PARP-pathway, which may be utilized to make BRCA (breast cancer susceptibility gene) mutant cancer cells more vulnerable to DNA damaging agents and kill them.

New Cytotoxic 19-Norbufadienolide and Bufogargarizin Isolated from Chan Su

Structurally diverse bufadienolides from the skins of Bufo bufo gargarizans and their cytotoxicity

A new bufadienolide from Bufo gargarizans Cantor

Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism

Microbial Transformation of Three Bufadienolides by Nocardia Sp. and Some Insight for the Cytotoxic Structure–activity Relationship (SAR)

Global Metabolomic and Lipidomic Analysis Reveal the Synergistic Effect of Bufalin in Combination with Cinobufagin Against HepG2 Cells.

Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

Two new bufadienolides from the rhizomes of Helleborus thibetanus Franch

Analysis of Bufadienolides in the Chinese Drug ChanSu by High-Performance Liquid Chromatography with Atmospheric Pressure Chemical Ionization Tandem Mass Spectrometry.

New cytotoxic bufadienolides from the roots and rhizomes of Helleborus thibetanus Franch

Enzymatic Synthesis of Bufadienolide O‐Glycosides as Potent Antitumor Agents Using a Microbial Glycosyltransferase

Isolation, Identification and Chemical Modification of Bufadienolides from Bufo melanostictus Schneider and Their Cytotoxic Activities against Prostate Cancer Cells

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Cytochrome P450 Mining for Bufadienolide Diversification

Simultaneous determination of cytotoxic bufadienolides in the Chinese medicine ChanSu by high-performance liquid chromatography coupled with photodiode array and mass spectrometry detections.

Synthesis and Structure–activity Relationships Study of Cytotoxic Bufalin 3-Nitrogen-containing-ester Derivatives

Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy

Biotransformation of Bufadienolides by Cell Suspension Cultures of Saussurea Involucrata

Bufadienolides from the Eggs of the Toad Bufo bufo gargarizans and Their Antimelanoma Activities

Preparative Separation and Purification of Bufadienolides from ChanSu by High-Speed Counter-Current Chromatography Combined with Preparative HPLC